165 related articles for article (PubMed ID: 8986534)
41. Epidermal growth factor-related peptides in the pathogenesis of human breast cancer.
Normanno N; Ciardiello F; Brandt R; Salomon DS
Breast Cancer Res Treat; 1994 Jan; 29(1):11-27. PubMed ID: 7912564
[TBL] [Abstract][Full Text] [Related]
42. Overexpression of transforming growth factor-alpha and epidermal growth factor receptor, but not epidermal growth factor, in exocrine pancreatic tumours in hamsters.
Visser CJ; Bruggink AH; Korc M; Kobrin MS; de Weger RA; Seifert-Bock I; van Blokland WT; van Garderen-Hoetmer A; Woutersen RA
Carcinogenesis; 1996 Apr; 17(4):779-85. PubMed ID: 8625491
[TBL] [Abstract][Full Text] [Related]
43. Quantitative analysis of follicle-stimulating hormone receptor in ovarian epithelial tumors: a novel approach to explain the field effect of ovarian cancer development in secondary mullerian systems.
Wang J; Lin L; Parkash V; Schwartz PE; Lauchlan SC; Zheng W
Int J Cancer; 2003 Jan; 103(3):328-34. PubMed ID: 12471615
[TBL] [Abstract][Full Text] [Related]
44. Numerical abnormalities of chromosomes 1, 11, 17, and X are associated with stromal invasion in serous and mucinous epithelial ovarian tumours.
Evans MF; McDicken IW; Herrington CS
J Pathol; 1999 Sep; 189(1):53-9. PubMed ID: 10451488
[TBL] [Abstract][Full Text] [Related]
45. Expression of epidermal growth factors and epidermal growth factor receptor in normal cycling human ovaries.
Tamura M; Sasano H; Suzuki T; Fukaya T; Funayama Y; Takayama K; Takaya R; Yajima A
Hum Reprod; 1995 Jul; 10(7):1891-6. PubMed ID: 8583007
[TBL] [Abstract][Full Text] [Related]
46. Decreased expression of epidermal growth factor receptor and mRNA of its ligands in Helicobacter pylori-infected gastric mucosa.
Schiemann U; Konturek JW; Osterhoff M; Assert R; Rembiasz K; Pfeiffer D; Schatz H; Domschke W; Pfeiffer A
Scand J Gastroenterol; 2001 Jan; 36(1):23-31. PubMed ID: 11218236
[TBL] [Abstract][Full Text] [Related]
47. Expression and action of transforming growth factor alpha in normal ovarian surface epithelium and ovarian cancer.
Doraiswamy V; Parrott JA; Skinner MK
Biol Reprod; 2000 Sep; 63(3):789-96. PubMed ID: 10952922
[TBL] [Abstract][Full Text] [Related]
48. Serum levels of epidermal growth factor, transforming growth factor, and c-erbB2 in ovarian cancer.
Balcan E; Demirkiran F; Aydin Y; Sanioglu C; Bese T; Arvas M; Akçay T; Cift T
Int J Gynecol Cancer; 2012 Sep; 22(7):1138-42. PubMed ID: 22914212
[TBL] [Abstract][Full Text] [Related]
49. Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines.
Ching KZ; Ramsey E; Pettigrew N; D'Cunha R; Jason M; Dodd JG
Mol Cell Biochem; 1993 Sep; 126(2):151-8. PubMed ID: 7508078
[TBL] [Abstract][Full Text] [Related]
50. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
[TBL] [Abstract][Full Text] [Related]
51. Clinicopathological study of metallothionein immunohistochemical expression, in benign, borderline and malignant ovarian epithelial tumors.
Zagorianakou N; Stefanou D; Makrydimas G; Zagorianakou P; Briasoulis E; Karavasilis V; Pavlidis N; Agnantis NJ
Histol Histopathol; 2006 Apr; 21(4):341-7. PubMed ID: 16437378
[TBL] [Abstract][Full Text] [Related]
52. Expression and prognostic value of epidermal growth factor receptor, transforming growth factor-alpha, and c-erb B-2 in nephroblastoma.
Ghanem MA; Van Der Kwast TH; Den Hollander JC; Sudaryo MK; Mathoera RB; Van den Heuvel MM; Noordzij MA; Nijman RJ; van Steenbrugge GJ
Cancer; 2001 Dec; 92(12):3120-9. PubMed ID: 11753991
[TBL] [Abstract][Full Text] [Related]
53. Epidermal growth factor family and renal cell carcinoma: expression and prognostic impact.
Hofmockel G; Riess S; Bassukas ID; Dämmrich J
Eur Urol; 1997; 31(4):478-84. PubMed ID: 9187911
[TBL] [Abstract][Full Text] [Related]
54. Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer.
Castellvi J; Garcia A; Rojo F; Ruiz-Marcellan C; Gil A; Baselga J; Ramon y Cajal S
Cancer; 2006 Oct; 107(8):1801-11. PubMed ID: 16983702
[TBL] [Abstract][Full Text] [Related]
55. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.
Rubin Grandis J; Melhem MF; Gooding WE; Day R; Holst VA; Wagener MM; Drenning SD; Tweardy DJ
J Natl Cancer Inst; 1998 Jun; 90(11):824-32. PubMed ID: 9625170
[TBL] [Abstract][Full Text] [Related]
56. Placental leucine aminopeptidase (P-LAP) and glucose transporter 4 (GLUT4) expression in benign, borderline, and malignant ovarian epithelia.
Shibata K; Kajiyama H; Mizokami Y; Ino K; Nomura S; Mizutani S; Terauchi M; Kikkawa F
Gynecol Oncol; 2005 Jul; 98(1):11-8. PubMed ID: 15907336
[TBL] [Abstract][Full Text] [Related]
57. Demonstration of neuroendocrine cells in ovarian mucinous tumors.
Sasaki E; Sasano N; Kimura N; Andoh N; Yajima A
Int J Gynecol Pathol; 1989; 8(3):189-200. PubMed ID: 2570045
[TBL] [Abstract][Full Text] [Related]
58. Expressions of epidermal growth factor family and its receptor in hepatocellular carcinoma cell lines: relationship to cell proliferation.
Hisaka T; Yano H; Haramaki M; Utsunomiya I; Kojiro M
Int J Oncol; 1999 Mar; 14(3):453-60. PubMed ID: 10024677
[TBL] [Abstract][Full Text] [Related]
59. Epidermal growth factor receptor and c-erbB-2 oncoproteins in tissue and tumor effusion cells of histopathologically different ovarian neoplasms.
Harlozińska A; Bar JK; Sobańska E; Goluda M
Tumour Biol; 1998; 19(5):364-73. PubMed ID: 9701727
[TBL] [Abstract][Full Text] [Related]
60. PAX2 and PAX8 reliably distinguishes ovarian serous tumors from mucinous tumors.
Wang M; Ma H; Pan Y; Xiao W; Li J; Yu J; He J
Appl Immunohistochem Mol Morphol; 2015 Apr; 23(4):280-7. PubMed ID: 24992169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
